ISS endgame: 2030 deorbit and the successor race
- The thread: the ISS endgame as one system — SpaceX's $843M US Deorbit Vehicle steering the ~430 t stack into Point Nemo late 2030/early 2031, Russia now signed through 2030, and the commercial successor field (Vast, Axiom, Starlab, Orbital Reef) racing a NASA CLD procurement that restructures faster than anyone can build hardware.
- 2026-09-10: opened. Keyed facts: deorbit vehicle awarded to SpaceX Jun 2024, up to $843M; Russia (previously committed only through 2028) agreed Jul 16 to support ISS ops through 2030 — Isaacman–Bakanov meetings; Krikalev had floated extension in March. Axiom dropped the attach-to-ISS-first assembly sequence Dec 2024 (free-flying PPTM first, Thales building), raised $350M Feb 2026 (Type One Ventures/QIA). Vast: Haven-1 in integration since Jan 2026, Q1 2027 target, slipped ~a year; Haven-2 is the ISS-replacement pitch. CLD: Phase 2 revised Aug 2025 directive, formally on hold Jan 28 2026, Mar 2026 'Ignition' restructuring walked back Jun 1 under industry pressure; Voyager seeking relaxed requirements in the pending RFP (Aug 4). Ocean-health/legal critique of the splashdown (Space.com Jun 23). Russia's ROS fully deployed by 2034 (TASS Apr 8).
- Watch for: final CLD RFP language (permanent-presence requirement in or out), Haven-1 slip beyond Q1 2027, Axiom's first-module date, whether NASA has a contracted destination before the deorbit vehicle flies.
- 2026-09-17: the commercial demand side formalizes — Reuters (~8:25 AM ET): drugmakers laying groundwork for commercial pharmaceutical R&D + manufacturing in LEO as ISS retirement nears, and working with regulators on rules for producing medicines in space. The successor race gets its pharma demand layer (see starfall); the new fact is regulator engagement — who certifies a drug made in orbit.
- 2026-09-23: a successor player widens its pitch — SpaceNews: Vast announces a lunar systems line, leveraging station technologies (power, habitation) for lunar infrastructure. Announcement-grade; the successor-race field is broadening its pitch while the CLD procurement stays stalled.
-
2026-09-29: the rival coalition staffs up — Pakistan's first astronaut boards Tiangong this fall (MSN syndication; two fighter pilots completed training), part of China's post-ISS partner coalition recruiting. The successor race now runs on both tracks: NASA's stalled CLD procurement vs China's state coalition — the geopolitical mirror of the thread.
-
2026-10-12 (RFP milestone): NASA issued the final commercial-station procurement RFP on Friday Oct 9 — TheStreet frames "doubling down" on private stations with the alternative approach "off the table"; SpaceNews/Foust corroborates. The line's standing watch ("final CLD RFP language: permanent-presence requirement in or out") has now been met. Watch: requirement text (permanent presence; Voyager's relaxed-terms ask), successor-field bids, whether a contracted destination exists before the $843M deorbit vehicle flies late 2030/early 2031. https://www.thestreet.com/markets/nasa-doubles-down-on-private-space-stations-to-replace-iss